C
INSM icon

Covestor’s Insmed INSM Stock Holding History

Covestor’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8K Sell
71
-15
-17% -$1.82K ﹤0.01% 1726
2026
Q1 		$14K Sell
86
-81
-49% -$12.5K 0.01% 1258
2025
Q4 		$29K Hold
167
– – 0.02% 1114
2025
Q3 		$24K Buy
167
+3
+2% +$368 0.01% 1209
2025
Q2 		$17K Hold
164
– – 0.01% 1309
2025
Q1 		$13K Buy
164
+1
+0.6% +$76 0.01% 1352
2024
Q4 		$11K Hold
163
– – 0.01% 1482
2024
Q3 		$12K Sell
163
-422
-72% -$31.1K 0.01% 1439
2024
Q2 		$39K Buy
585
+578
+8,257% +$22.4K 0.03% 959
2024
Q1 		$0 Hold
7
– – ﹤0.01% 2470
2023
Q4 		$0 Sell
7
-1
-13% -$26 ﹤0.01% 2391
2023
Q3 		$0 Sell
8
-163
-95% -$3.73K ﹤0.01% 2378
2023
Q2 		$4K Sell
171
-625
-79% -$11.9K ﹤0.01% 1726
2023
Q1 		$14K Buy
796
+787
+8,744% +$15.3K 0.01% 1145
2022
Q4 		$0 Sell
9
-1
-10% -$19 ﹤0.01% 2306
2022
Q3 		$0 Sell
10
-5
-33% -$120 ﹤0.01% 2270
2022
Q2 		$0 Sell
15
-4
-21% -$84 ﹤0.01% 2120
2022
Q1 		$0 Sell
19
-5
-21% -$116 ﹤0.01% 2264
2021
Q4 		$1K Buy
+24
New +$686 ﹤0.01% 1788

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Covestor's INSM Position: Q2 2026 in Review

Covestor reduced its Insmed (INSM) stake by 17% in Q2 2026, selling an estimated $1.82K and leaving 71 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Covestor first reported a position in INSM in Q4 2021 and has held it in 19 quarters since. The position peaked at $39K in Q2 2024. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Covestor held 71 shares of Insmed worth $8K as of Q2 2026.
  • Covestor sold 15 Insmed shares in Q2 2026, an estimated $1.82K.
  • Insmed made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #1726 holding.
  • Covestor first reported a position in Insmed in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Insmed position peaked at $39K in Q2 2024.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.